DETECTION OF SINGLE NUCLEOTIDE POLYMORPHISMS

Details for Australian Patent Application No. 2002312155 (hide)

Owner XANTHON, INC.

Inventors ECKHARDT, Allen, E.

Pub. Number AU-A-2002312155

PCT Number PCT/US02/16993

PCT Pub. Number WO2002/099137

Priority 09/873,809 04.06.01 US

Filing date 31 May 2002

Wipo publication date 16 December 2002

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 09/873,809 04.06.01 US

8 May 2003 Application Open to Public Inspection

  Published as AU-A-2002312155

12 February 2004 Section 223 Application Allowed

  XANTHON, INC. The time in which to enter the National Phase has been extended to 06 Jan 2004. Address for service in Australia - Freehills Carter Smith Beadle Level 43 101 Collins Street Melbourne VIC 3000 2003

24 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002312156-INTERLABIAL PAD WITH FINGERRECEIVING POSITIONING AID

2002312154-Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture